Evaluating effect of teriflunomide on cortical atrophy in a subgroup analysis of patients defined by baseline MRI activity in the Phase 3 TOPIC study

被引：0
|
作者：
Zivadinov, R. [1 ]
Dwyer, M. G. [1 ]
Carl, E. [1 ]
Thangavelu, K. [2 ]
Cavalier, S. [2 ]
Bergsland, N. [1 ]
机构：
[1] Univ Buffalo, Buffalo, NY USA
[2] Sanofi Genzyme, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PR2092
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [31] Analysis of Post-treatment Relapse Activity in the Phase 3 OPTIMUM Study of Ponesimod Compared with Teriflunomide (P1-1.Virtual)
    Kappos, Ludwig
    Fox, Robert
    Burcklen, Michel
    Freedman, Mark
    Hennessy, Brian
    Stos, Antoine
    Linscheid, Philippe
    Vaclavkova, Andrea
    Kracker, Hilke
    Sidorenko, Tatiana
    Pozzilli, Carlo
    NEUROLOGY, 2022, 98 (18)
  • [32] Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
    Demetri, George D.
    Schoffski, Patrick
    Grignani, Giovanni
    Blay, Jean-Yves
    Maki, Robert G.
    Van Tine, Brian A.
    Alcindor, Thierry
    Jones, Robin L.
    D'Adamo, David R.
    Guo, Matthew
    Chawla, Sant
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (30) : 3433 - +
  • [33] Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph plus ALL: Subgroup Analysis of the Phase 3 Phallcon Study
    Aldoss, Ibrahim
    Ribera, Josep-Maria
    Kantarjian, Hagop
    Montesinos, Pau
    Leonard, Jessica T.
    Gomez-Almaguer, David
    Baer, Maria R.
    Gambacorti-Passerini, Carlo
    McCloskey, James
    Minami, Yosuke
    Papayannidis, Cristina
    Rocha, Vanderson
    Rousselot, Philippe
    Vachhani, Pankit
    Wang, Eunice S.
    Hennessy, Meliessa
    Patel, Niti
    Vorog, Alexander
    Wang, Bingxia
    Jabbour, Elias
    BLOOD, 2023, 142
  • [34] Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
    Blay, Jean-Yves
    Schoffski, Patrick
    Bauer, Sebastian
    Krarup-Hansen, Anders
    Benson, Charlotte
    D'Adamo, David R.
    Jia, Yan
    Maki, Robert G.
    BRITISH JOURNAL OF CANCER, 2019, 120 (11) : 1026 - 1032
  • [35] Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
    Jean-Yves Blay
    Patrick Schöffski
    Sebastian Bauer
    Anders Krarup-Hansen
    Charlotte Benson
    David R. D’Adamo
    Yan Jia
    Robert G. Maki
    British Journal of Cancer, 2019, 120 : 1026 - 1032
  • [36] Effect of oral ponesimod on clinical disease activity and mri-based outcomes in patients with relapsing multiple sclerosis: phase 3 optimum study
    Kappos, L.
    Burcklen, M.
    Freedman, M.
    Fox, R.
    Havrdova, E. Kubala
    Hennessy, B.
    Hohlfeld, R.
    Lublin, F.
    Montalban, X.
    Pozzilli, C.
    Scherz, T.
    Linscheid, P.
    Pirozek-Lawniczek, M.
    Ford, L.
    Kracker, H.
    Wuerfel, J.
    Sprenger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 151 - 152
  • [37] Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD-CHN3
    Tong, Guoyu
    Lu, Song
    Kuang, Hongyu
    Li, Yan
    Deng, Yuying
    Lou, Ying
    Wang, Weimin
    Zhu, Dalong
    DIABETES OBESITY & METABOLISM, 2024, 26 (04): : 1540 - 1543
  • [38] Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes
    Kaneko, Shizuka
    Oura, Tomonori
    Matsui, Akiko
    Shingaki, Tomotaka
    Takeuchi, Masakazu
    ENDOCRINE JOURNAL, 2017, 64 (12) : 1165 - 1172
  • [39] Analyses of the Effect of Baseline Age on the Efficacy and Safety of Siponimod in Patients with Active SPMS from the Phase 3 EXPAND Study
    Hua, Le H.
    Bar-Or, Amit
    Lublin, Fred
    Meng, Xiangyi
    Su, Wendy
    Cree, Bruce A. C.
    Fox, Robert J.
    NEUROLOGY, 2021, 96 (15)
  • [40] Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients
    You, Chur Woo
    Baek, Hee Jo
    Park, Sang Kyu
    Park, Young Shil
    Shin, Ho-Jin
    Engl, Werner
    Tangada, Srilatha
    BLOOD RESEARCH, 2019, 54 (03) : 198 - 203
12345